Cargando…

Impact of different surgical and postoperative adjuvant treatment modalities on survival of sinonasal malignant melanoma

BACKGROUND: The role of postoperative adjuvant treatment for sinonasal malignant melanoma remains unclear. This study evaluates the impact of three different surgical and postoperative adjuvant treatment modalities: surgery alone(open and endoscopic approaches), surgery plus radiotherapy and surgery...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Xin-Jun, Ao, Hua-Fei, Huang, Wei-Ting, Chen, Fu, Sun, Xi-Cai, Wang, Jing-Jing, Liu, Zhuo-Fu, Han, Wade W, Fry, Allison N, Wang, De-Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4152585/
https://www.ncbi.nlm.nih.gov/pubmed/25149057
http://dx.doi.org/10.1186/1471-2407-14-608
_version_ 1782333147550056448
author Meng, Xin-Jun
Ao, Hua-Fei
Huang, Wei-Ting
Chen, Fu
Sun, Xi-Cai
Wang, Jing-Jing
Liu, Zhuo-Fu
Han, Wade W
Fry, Allison N
Wang, De-Hui
author_facet Meng, Xin-Jun
Ao, Hua-Fei
Huang, Wei-Ting
Chen, Fu
Sun, Xi-Cai
Wang, Jing-Jing
Liu, Zhuo-Fu
Han, Wade W
Fry, Allison N
Wang, De-Hui
author_sort Meng, Xin-Jun
collection PubMed
description BACKGROUND: The role of postoperative adjuvant treatment for sinonasal malignant melanoma remains unclear. This study evaluates the impact of three different surgical and postoperative adjuvant treatment modalities: surgery alone(open and endoscopic approaches), surgery plus radiotherapy and surgery, radiotherapy plus chemotherapy on survival of patients with primary sinonasal malignant melanoma (SMM). METHODS: The data of 69 patients who underwent primary surgical treatments at Eye & ENT hospital of Fudan University between January 1st, 2000 and December 31st, 2010 were retrospectively reviewed. Survival comparison of different surgical and postoperative adjuvant treatment modalities (surgery alone, surgery plus radiotherapy and surgery, radiotherapy plus chemotherapy), as well as survival comparison between open and endoscopic surgical approaches were performed. Curves depicting survival were performed using Kaplan-Meier method. Statistical analysis was performed using log-rank test software SPSS19 and p < .05 is considered as statistically significant. RESULTS: The median overall survival time was found to be 18 months for surgery alone (27 cases), 32 months for surgery plus radiotherapy (24 cases), 42 months for surgery, radiotherapy plus chemotherapy (18 cases). The 3 and 5 year survival rates for groups mentioned above were 14.8% and 5.6%, 45.1% and 31.6%, 55% and 32.1%, respectively. Statistical significances were found not only between surgery alone and surgery plus radiotherapy treatment group (P = 0.012), but also surgery alone and surgery, radiotherapy plus chemotherapy group (P = 0.002). There was no statistically significant survival difference found between the two different surgical approaches (41 cases for open approach and 28 cases for endoscopic approach). CONCLUSIONS: Sinonasal malignant melanoma is a disease with a poor prognosis. Patients who underwent surgery plus radiotherapy or surgery, radiotherapy plus chemotherapy had better survival outcomes than those underwent surgery alone. Endoscopic approach provided similar survival outcome as an open approach.
format Online
Article
Text
id pubmed-4152585
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41525852014-09-04 Impact of different surgical and postoperative adjuvant treatment modalities on survival of sinonasal malignant melanoma Meng, Xin-Jun Ao, Hua-Fei Huang, Wei-Ting Chen, Fu Sun, Xi-Cai Wang, Jing-Jing Liu, Zhuo-Fu Han, Wade W Fry, Allison N Wang, De-Hui BMC Cancer Research Article BACKGROUND: The role of postoperative adjuvant treatment for sinonasal malignant melanoma remains unclear. This study evaluates the impact of three different surgical and postoperative adjuvant treatment modalities: surgery alone(open and endoscopic approaches), surgery plus radiotherapy and surgery, radiotherapy plus chemotherapy on survival of patients with primary sinonasal malignant melanoma (SMM). METHODS: The data of 69 patients who underwent primary surgical treatments at Eye & ENT hospital of Fudan University between January 1st, 2000 and December 31st, 2010 were retrospectively reviewed. Survival comparison of different surgical and postoperative adjuvant treatment modalities (surgery alone, surgery plus radiotherapy and surgery, radiotherapy plus chemotherapy), as well as survival comparison between open and endoscopic surgical approaches were performed. Curves depicting survival were performed using Kaplan-Meier method. Statistical analysis was performed using log-rank test software SPSS19 and p < .05 is considered as statistically significant. RESULTS: The median overall survival time was found to be 18 months for surgery alone (27 cases), 32 months for surgery plus radiotherapy (24 cases), 42 months for surgery, radiotherapy plus chemotherapy (18 cases). The 3 and 5 year survival rates for groups mentioned above were 14.8% and 5.6%, 45.1% and 31.6%, 55% and 32.1%, respectively. Statistical significances were found not only between surgery alone and surgery plus radiotherapy treatment group (P = 0.012), but also surgery alone and surgery, radiotherapy plus chemotherapy group (P = 0.002). There was no statistically significant survival difference found between the two different surgical approaches (41 cases for open approach and 28 cases for endoscopic approach). CONCLUSIONS: Sinonasal malignant melanoma is a disease with a poor prognosis. Patients who underwent surgery plus radiotherapy or surgery, radiotherapy plus chemotherapy had better survival outcomes than those underwent surgery alone. Endoscopic approach provided similar survival outcome as an open approach. BioMed Central 2014-08-23 /pmc/articles/PMC4152585/ /pubmed/25149057 http://dx.doi.org/10.1186/1471-2407-14-608 Text en © Meng et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Meng, Xin-Jun
Ao, Hua-Fei
Huang, Wei-Ting
Chen, Fu
Sun, Xi-Cai
Wang, Jing-Jing
Liu, Zhuo-Fu
Han, Wade W
Fry, Allison N
Wang, De-Hui
Impact of different surgical and postoperative adjuvant treatment modalities on survival of sinonasal malignant melanoma
title Impact of different surgical and postoperative adjuvant treatment modalities on survival of sinonasal malignant melanoma
title_full Impact of different surgical and postoperative adjuvant treatment modalities on survival of sinonasal malignant melanoma
title_fullStr Impact of different surgical and postoperative adjuvant treatment modalities on survival of sinonasal malignant melanoma
title_full_unstemmed Impact of different surgical and postoperative adjuvant treatment modalities on survival of sinonasal malignant melanoma
title_short Impact of different surgical and postoperative adjuvant treatment modalities on survival of sinonasal malignant melanoma
title_sort impact of different surgical and postoperative adjuvant treatment modalities on survival of sinonasal malignant melanoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4152585/
https://www.ncbi.nlm.nih.gov/pubmed/25149057
http://dx.doi.org/10.1186/1471-2407-14-608
work_keys_str_mv AT mengxinjun impactofdifferentsurgicalandpostoperativeadjuvanttreatmentmodalitiesonsurvivalofsinonasalmalignantmelanoma
AT aohuafei impactofdifferentsurgicalandpostoperativeadjuvanttreatmentmodalitiesonsurvivalofsinonasalmalignantmelanoma
AT huangweiting impactofdifferentsurgicalandpostoperativeadjuvanttreatmentmodalitiesonsurvivalofsinonasalmalignantmelanoma
AT chenfu impactofdifferentsurgicalandpostoperativeadjuvanttreatmentmodalitiesonsurvivalofsinonasalmalignantmelanoma
AT sunxicai impactofdifferentsurgicalandpostoperativeadjuvanttreatmentmodalitiesonsurvivalofsinonasalmalignantmelanoma
AT wangjingjing impactofdifferentsurgicalandpostoperativeadjuvanttreatmentmodalitiesonsurvivalofsinonasalmalignantmelanoma
AT liuzhuofu impactofdifferentsurgicalandpostoperativeadjuvanttreatmentmodalitiesonsurvivalofsinonasalmalignantmelanoma
AT hanwadew impactofdifferentsurgicalandpostoperativeadjuvanttreatmentmodalitiesonsurvivalofsinonasalmalignantmelanoma
AT fryallisonn impactofdifferentsurgicalandpostoperativeadjuvanttreatmentmodalitiesonsurvivalofsinonasalmalignantmelanoma
AT wangdehui impactofdifferentsurgicalandpostoperativeadjuvanttreatmentmodalitiesonsurvivalofsinonasalmalignantmelanoma